Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Clinical trial NCT06647953 · RECRUITING
Trial details
- NCT number
- NCT06647953
- Sponsor
- Children's Oncology Group
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-21
- Primary completion
- 2029-03-31
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.